Description
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.
Cat.No
A469
Name
Motavizumab
Chemical Properties
CAS
677010-34-3
Synonyms
Motavizumab;Numax;(5S,8S,11S,14S,17S,20S,23S,26R,29S,32S,35S)-5-Amino-20-[(2S)-2-butanyl]-6,13,16,19,24,31-hexahydroxy;Research Grade Motavizumab(DVV02803);Motavizumab (anti-RSV-F)
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
